Pharmaceutical Industry
IndiaRF begins stake sale process in Synthimed Labs, appoints Rothschild & Co
India Resurgence Fund has appointed Rothschild to sell a minority stake in API and CRAMS firm Synthimed Labs, seeking a $1 billion valuation a little over two years after acquiring the asset.
3 min read21 Dec 2025The day pharma’s weight-loss gold rush intensified
Lilly’s quarterly results Thursday, combined with Novo Nordisk’s unsolicited offer for a startup, confirm the $72 billion anti-obesity market is among pharma’s hottest.
4 min read31 Oct 2025Amitabh Dube of Novartis India on his journey from med rep to Big Pharma man
Novartis India’s president and MD on his belief that AI can lead to faster diagnoses, why Big Pharma doesn't deserve its reputation, and his love for Vietnam
7 min read11 Oct 2025Centre orders strict drug testing after toxic cough syrup kills 14 children
The DCGI directive noted that during investigations into manufacturing facilities, it was observed that some drugmakers were not carrying out the mandatory testing of each batch of excipients and active pharmaceutical ingredients, in direct violation of the Drugs Rules, 1945.
2 min read8 Oct 2025Trump wants to overhaul drug sales. A company tied to his son stands to benefit.
The family members of President Trump and Commerce Secretary Howard Lutnick are poised to benefit from efforts to remake the pharmaceutical industry.
5 min read8 Oct 2025India to rewrite drug-quality rulebook to match US, EU, Japan standards
India is setting up new standards for 123 drugs, and updating them for another 200 medicines, as it aims to align with the benchmarks in the US, Japan, and the European Union.
4 min read24 Sep 2025Drugmakers have pledged to invest $350 billion in US after tariff threat
GSK and Eli Lilly are the latest to unveil plans to add to manufacturing and increase other operations in America.
3 min read17 Sep 2025Layoffs loom at weight loss drug Wegovy's maker Novo Nordisk as slowing sales threaten job cuts
Novo Nordisk raced to meet demand for its weight-loss drug Wegovy and almost doubled its workforce over five years. Now, the rapid expansion is under scrutiny amid cost pressures, and the new CEO is looking for cost cuts.
3 min read21 Aug 2025Indian drugmakers aim to boost exports to Mexico, South America's No. 2 pharma market
India seeks to significantly boost its medicine exports to Mexico, a market currently valued at over $20 billion and expected to grow to $38.5 billion by 2033. Domestic pharmaceuticals account for only $180 million as they face complex rules and regulatory hurdles.
2 min read18 Aug 2025Trump wants cheaper drugs like Europe has. How it works.
The president wants a the most-favored-nation pricing model. But the U.S. drug industry is offering a host of reasons why that isn’t a good idea.
3 min read12 Jun 2025Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.